1
|
Boukrouh S, Noutfia A, Moula N, Avril C, Louvieaux J, Hornick JL, Cabaraux JF, Chentouf M. Ecological, morpho-agronomical, and bromatological assessment of sorghum ecotypes in Northern Morocco. Sci Rep 2023; 13:15548. [PMID: 37730680 PMCID: PMC10511723 DOI: 10.1038/s41598-023-41565-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Accepted: 08/29/2023] [Indexed: 09/22/2023] Open
Abstract
Sorghum Bicolor is a cereal used for grains as feed and food, mainly cultivated in dry areas. To study the possibilities of increasing its cultivation for feed purposes, ecological, morpho-agronomical, and bromatological characterization of some local ecotypes was conducted as the first steps toward selecting better cultivars. Indeed, twenty-one ecotypes were collected from farms in Northern Morocco in 2018. The edapho-climatic parameters of the collection sites were evaluated. The ecotypes were cultivated in 2019 in an experimental field with a randomized complete block design with three replicates. At the maturity stage, plants were evaluated for agro-morphological parameters, and grains and straw (leaves and stems) were harvested and analyzed. The results indicated significant variations between ecotypes for almost all parameters and an interesting grain yield of 3.5 T/ha with a 176% yield variation. The nutritive value of grains was interesting compared to straw, especially for mean protein contents (10.5% DM) and organic matter digestibility (81.4%). The calculated genetic parameters emphasized the possibility of selecting highly productive and nutritive cultivars. Multivariate analysis clustered the ecotypes into five groups based on agro-morphological, bromatological, and antioxidant activity parameters; the third group was characterized by high grain-yielding ecotypes, and the fifth one by high nutritive ecotypes. The E21 ecotype, belonging to this last group, was a promising selection candidate as it combines both. No significant correlation link between agro-morphological and bromatological traits of grains and geographical distances was discerned. Sorghum bicolor could thus be improved only according to the researched agro-morphological and bromatological traits.
Collapse
Affiliation(s)
- S Boukrouh
- Department of Veterinary Management of Animal Resources, FARAH Center, Faculty of Veterinary Medicine, University of Liège, 4000, Liège, Belgium.
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco.
| | - A Noutfia
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco
| | - N Moula
- Department of Veterinary Management of Animal Resources, FARAH Center, Faculty of Veterinary Medicine, University of Liège, 4000, Liège, Belgium
| | - C Avril
- Haute École Provinciale de Hainaut Condorcet, Agronomy Category, 7800, Ath, Belgium
| | - J Louvieaux
- Haute École Provinciale de Hainaut Condorcet, Agronomy Category, 7800, Ath, Belgium
| | - J L Hornick
- Department of Veterinary Management of Animal Resources, FARAH Center, Faculty of Veterinary Medicine, University of Liège, 4000, Liège, Belgium
| | - J F Cabaraux
- Department of Veterinary Management of Animal Resources, FARAH Center, Faculty of Veterinary Medicine, University of Liège, 4000, Liège, Belgium.
| | - M Chentouf
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco
| |
Collapse
|
2
|
Boukrouh S, Noutfia A, Moula N, Avril C, Louvieaux J, Hornick JL, Chentouf M, Cabaraux JF. Ecological, morpho-agronomical, and nutritional characteristics of Sulla flexuosa (L.) Medik. ecotypes. Sci Rep 2023; 13:13300. [PMID: 37587206 PMCID: PMC10432491 DOI: 10.1038/s41598-023-40148-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 08/05/2023] [Indexed: 08/18/2023] Open
Abstract
The present work was part of assessing wild genetic plant resources of forage interest in Northern Morocco and aimed to study the agro-morphology and nutritional value of Sulla flexuosa (L.) Medik. (Hedysarum flexuosum L.) ecotypes. The seeds of twenty-one wild S. flexuosa (L.) Medik. ecotypes were collected from 21 sites. The edaphic and climatic characteristics of the collection sites were studied and testified to the remarkable adaptability of S. flexuosa (L.) Medik. These 21 ecotypes were cultivated in three complete randomized blocks design for two consecutive years. Statistical analysis showed substantial variability between the collected ecotypes. Principal component analysis and heatmap analysis allowed to distinguish four groups of ecotypes mainly based on nutritional parameters (fiber content and digestibility), forage production (dry matter yield, number of leaves per plant, and total number of branches), and reproduction (number of inflorescences per plant and, weight of thousand seeds and seeds per plant). Furthermore, the present study pointed out the value of ecotype 1, which was dual purpose with its high productivity, nutritional value, and reproductive parameters. Ecotype 4 was also highlighted as having late flowering but intermediate productivity, which can be used mainly for haymaking as the drying period could coincide with the last rainfall in the region.
Collapse
Affiliation(s)
- S Boukrouh
- Department of Veterinary Management of Animal Resources, Faculty of Veterinary Medicine, FARAH Center, University of Liège, 4000, Liège, Belgium.
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco.
| | - A Noutfia
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco
| | - N Moula
- Department of Veterinary Management of Animal Resources, Faculty of Veterinary Medicine, FARAH Center, University of Liège, 4000, Liège, Belgium
| | - C Avril
- Haute École Provinciale de Hainaut Condorcet, Agronomy Category, 7800, Ath, Belgium
| | - J Louvieaux
- Haute École Provinciale de Hainaut Condorcet, Agronomy Category, 7800, Ath, Belgium
| | - J L Hornick
- Department of Veterinary Management of Animal Resources, Faculty of Veterinary Medicine, FARAH Center, University of Liège, 4000, Liège, Belgium
| | - M Chentouf
- Regional Center of Agricultural Research of Tangier, National Institute of Agricultural Research, 10090, Rabat, Morocco
| | - J F Cabaraux
- Department of Veterinary Management of Animal Resources, Faculty of Veterinary Medicine, FARAH Center, University of Liège, 4000, Liège, Belgium.
| |
Collapse
|
3
|
Tassou A, Thouaye M, Gilabert D, Jouvenel A, Leyris JP, Sonrier C, Diouloufet L, Mechaly I, Mallié S, Bertin J, Chentouf M, Neiveyans M, Pugnière M, Martineau P, Robert B, Capdevila X, Valmier J, Rivat C. Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain. Prog Neurobiol 2023; 222:102405. [PMID: 36646299 DOI: 10.1016/j.pneurobio.2023.102405] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 12/16/2022] [Accepted: 01/12/2023] [Indexed: 01/15/2023]
Abstract
Acute pain has been associated with persistent pain sensitization of nociceptive pathways increasing the risk of transition from acute to chronic pain. We demonstrated the critical role of the FLT3- tyrosine kinase receptor, expressed in sensory neurons, in pain chronification after peripheral nerve injury. However, it is unclear whether injury-induced pain sensitization can also promote long-term mood disorders. Here, we evaluated the emotional and sensorial components of pain after a single (SI) or double paw incision (DI) and the implication of FLT3. DI mice showed an anxiodepressive-like phenotype associated with extended mechanical pain hypersensitivity and spontaneous pain when compared to SI mice. Behavioral exaggeration was associated with peripheral and spinal changes including increased microglia activation after DI versus SI. Intrathecal microglial inhibitors not only eliminated the exaggerated pain hypersensitivity produced by DI but also prevented anxiodepressive-related behaviors. Behavioral and cellular changes produced by DI were blocked in Flt3 knock-out animals and recapitulated by repeated intrathecal FL injections in naive animals. Finally, humanized antibodies against FLT3 reduced DI-induced behavioral and microglia changes. Altogether our results show that the repetition of peripheral lesions facilitate not only exaggerated nociceptive behaviors but also induced anxiodepressive disorders supported by spinal central changes that can be blocked by targeting peripheral FLT3.
Collapse
Affiliation(s)
- Adrien Tassou
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Maxime Thouaye
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Damien Gilabert
- Univ Montpellier, Montpellier, France; CNRS UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France
| | - Antoine Jouvenel
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Jean-Philippe Leyris
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France; BIODOL Therapeutics, Cap Alpha, Clapiers, France
| | - Corinne Sonrier
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France; BIODOL Therapeutics, Cap Alpha, Clapiers, France
| | - Lucie Diouloufet
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France; BIODOL Therapeutics, Cap Alpha, Clapiers, France
| | - Ilana Mechaly
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Sylvie Mallié
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Juliette Bertin
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France; BIODOL Therapeutics, Cap Alpha, Clapiers, France
| | - Myriam Chentouf
- Univ Montpellier, Montpellier, France; IRCM, INSERM U1194, ICM, Montpellier F-34298, France
| | - Madeline Neiveyans
- Univ Montpellier, Montpellier, France; IRCM, INSERM U1194, ICM, Montpellier F-34298, France
| | - Martine Pugnière
- Univ Montpellier, Montpellier, France; IRCM, INSERM U1194, ICM, Montpellier F-34298, France
| | - Pierre Martineau
- Univ Montpellier, Montpellier, France; IRCM, INSERM U1194, ICM, Montpellier F-34298, France
| | - Bruno Robert
- Univ Montpellier, Montpellier, France; IRCM, INSERM U1194, ICM, Montpellier F-34298, France
| | - Xavier Capdevila
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France; Département d'anesthésiologie, Hôpital Universitaire Lapeyronie, Montpellier, France
| | - Jean Valmier
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France
| | - Cyril Rivat
- Univ Montpellier, Montpellier, France; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France.
| |
Collapse
|
4
|
Kchikich A, Kirschvink N, El Kadili S, Raes M, El Otmani S, Bister JL, El Amiri B, Barrijal S, Chentouf M. Thymus satureioides and Origanum majorana essential oils improve the quality of Beni Arouss buck semen during storage at 4°C. Reprod Domest Anim 2021; 56:1572-1581. [PMID: 34597454 DOI: 10.1111/rda.14022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Accepted: 09/29/2021] [Indexed: 12/01/2022]
Abstract
This study aims to investigate the effects of essential oils (EOs), extracted from Thymus satureioides (TS) and Origanum majorana (OM), on Beni Arouss buck semen quality stored in skimmed milk at 4°C. EOs were extracted by hydro-distillation, and the chemical compounds were determined. Ejaculates were collected from six Beni Arouss bucks, once a week for 10 weeks, and they were pooled, divided into five equal aliquots and diluted to 400 × 106 sperm/ml with skimmed milk supplemented with 0.01% of OM EO, 0.01% of TS EO, 0.05% of OM EO and 0.05% of TS EO. Non-supplemented skimmed milk was considered as a control. Semen motility, kinematic parameters, viability, abnormality, membrane integrity and lipid peroxidation were evaluated at 0, 4, 8, 24, 28, 32 and 48 hr of liquid storage at 4°C. The main EO components were carvacrol (31.7%), thymol (28.0%) and borneol (14.4%) for TS, and terpinene-4-ol (31.2%), γ-terpinene (17.4%) and α-terpinene (12.7%) for OM. The results highlighted a dose-dependent effect of TS and OM EOs on all semen quality parameters. 0.01% of both EOs had a beneficial effect on the sperm preservation stored at 4°C compared with control (p < .05) excepted for the straight-line velocity. The 0.05% EO addition had harmful effects during storage particularly for TS EO. In conclusion, 0.01% of TS and OM EOs are recommended to improve the Beni Arouss buck semen preservation at 4°C.
Collapse
Affiliation(s)
- A Kchikich
- Department of Biology, Faculté des Sciences et Techniques de Tanger, Ancienne Route de l'Aéroport, Tangier, Morocco.,National Institute of Agricultural Research, Regional Center of Agricultural Research of Tangier, Rabat, Morocco
| | - N Kirschvink
- Department of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium
| | - S El Kadili
- Department of Animal Production, Ecole Nationale d'Agriculture de Meknès, Meknes, Morocco
| | - M Raes
- Department of Veterinary Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium
| | - S El Otmani
- National Institute of Agricultural Research, Regional Center of Agricultural Research of Tangier, Rabat, Morocco
| | - J L Bister
- Department of Veterinary Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium
| | - B El Amiri
- National Institute of Agricultural Research, Regional Center of Agricultural Research of Settat, Rabat, Morocco
| | - S Barrijal
- Department of Biology, Faculté des Sciences et Techniques de Tanger, Ancienne Route de l'Aéroport, Tangier, Morocco
| | - M Chentouf
- National Institute of Agricultural Research, Regional Center of Agricultural Research of Tangier, Rabat, Morocco
| |
Collapse
|
5
|
Chauvin M, Garambois V, Choblet S, Colombo PE, Chentouf M, Gros L, De Brauwere DP, Duonor-Cerutti M, Dumas K, Robert B, Jarlier M, Martineau P, Navarro-Teulon I, Pépin D, Chardès T, Pèlegrin A. Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival. Int J Oncol 2021; 59:43. [PMID: 34013359 PMCID: PMC8131086 DOI: 10.3892/ijo.2021.5223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Accepted: 03/11/2021] [Indexed: 11/27/2022] Open
Abstract
Anti‑Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets in ovarian carcinoma. Conversely, the role of the three AMH type I receptors (AMHRIs), namely activin receptor‑like kinase (ALK)2, ALK3 and ALK6, in ovarian cancer remains to be clarified. To determine the respective roles of these three AMHRIs, the present study used four ovarian cancer cell lines (COV434‑AMHRII, SKOV3‑AMHRII, OVCAR8, KGN) and primary cells isolated from tumor ascites from patients with ovarian cancer. The results demonstrated that ALK2 and ALK3 may be the two main AMHRIs involved in AMH signaling at physiological endogenous and supraphysiological exogenous AMH concentrations, respectively. Supraphysiological AMH concentrations (25 nM recombinant AMH) were associated with apoptosis in all four cell lines and decreased clonogenic survival in COV434‑AMHRII and SKOV3‑AMHRII cells. These biological effects were induced via ALK3 recruitment by AMHRII, as ALK3‑AMHRII dimerization was favored at increasing AMH concentrations. By contrast, ALK2 was associated with AMHRII at physiological endogenous concentrations of AMH (10 pM). Based on these results, tetravalent IgG1‑like bispecific antibodies (BsAbs) against AMHRII and ALK2, and against AMHRII and ALK3 were designed and evaluated. In vivo, COV434‑AMHRII tumor cell xenograft growth was significantly reduced in all BsAb‑treated groups compared with that in the vehicle group (P=0.018 for BsAb 12G4‑3D7; P=0.001 for all other BsAbs). However, the growth of COV434‑AMHRII tumor cell xenografts was slower in mice treated with the anti‑AMRII‑ALK2 BsAb 12G4‑2F9 compared with that in animals that received a control BsAb that targeted AMHRII and CD5 (P=0.048). These results provide new insights into type I receptor specificity in AMH signaling pathways and may lead to an innovative therapeutic approach to modulate AMH signaling using anti‑AMHRII/anti‑AMHRI BsAbs.
Collapse
Affiliation(s)
- Maëva Chauvin
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - Véronique Garambois
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - Sylvie Choblet
- CNRS UPS3044 Baculovirus et Thérapie, F-30380 Saint-Christol-Lèz Alès, France
| | - Pierre-Emmanuel Colombo
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, F-34298 Montpellier, France
| | - Myriam Chentouf
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - Laurent Gros
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | | | | | | | - Bruno Robert
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - Marta Jarlier
- Institut Régional du Cancer de Montpellier, ICM, F-34298 Montpellier, France
| | - Pierre Martineau
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - Isabelle Navarro-Teulon
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - David Pépin
- Department of Surgery, Harvard Medical School, Boston, MA 02114, USA
- Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Thierry Chardès
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| | - André Pèlegrin
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, F-34298 Montpellier, France
| |
Collapse
|
6
|
Chauvin M, Garambois V, Colombo PE, Chentouf M, Gros L, Brouillet JP, Robert B, Jarlier M, Dumas K, Martineau P, Navarro-Teulon I, Pépin D, Chardès T, Pèlegrin A. Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells. Sci Rep 2021; 11:2231. [PMID: 33500516 PMCID: PMC7838181 DOI: 10.1038/s41598-021-81819-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Accepted: 01/12/2021] [Indexed: 12/30/2022] Open
Abstract
In ovarian carcinoma, anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets. Here, AMH dose-dependent effect on signaling and proliferation was analyzed in four ovarian cancer cell lines, including sex cord stromal/granulosa cell tumors and high grade serous adenocarcinomas (COV434-AMHRII, SKOV3-AMHRII, OVCAR8 and KGN). As previously shown, incubation with exogenous AMH at concentrations above the physiological range (12.5-25 nM) decreased cell viability. Conversely, physiological concentrations of endogenous AMH improved cancer cell viability. Partial AMH depletion by siRNAs was sufficient to reduce cell viability in all four cell lines, by 20% (OVCAR8 cells) to 40% (COV434-AMHRII cells). In the presence of AMH concentrations within the physiological range (5 to 15 pM), the newly developed anti-AMH B10 antibody decreased by 25% (OVCAR8) to 50% (KGN) cell viability at concentrations ranging between 3 and 333 nM. At 70 nM, B10 reduced clonogenic survival by 57.5%, 57.1%, 64.7% and 37.5% in COV434-AMHRII, SKOV3-AMHRII, OVCAR8 and KGN cells, respectively. In the four cell lines, B10 reduced AKT phosphorylation, and increased PARP and caspase 3 cleavage. These results were confirmed in ovarian cancer cells isolated from patients' ascites, demonstrating the translational potential of these results. Furthermore, B10 reduced COV434-MISRII tumor growth in vivo and significantly enhanced the median survival time compared with vehicle (69 vs 60 days; p = 0.0173). Our data provide evidence for a novel pro-survival autocrine role of AMH in the context of ovarian cancer, which was targeted therapeutically using an anti-AMH antibody to successfully repress tumor growth.
Collapse
Affiliation(s)
- Maëva Chauvin
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
- Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA, USA
| | - Véronique Garambois
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Pierre-Emmanuel Colombo
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Myriam Chentouf
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Laurent Gros
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Jean-Paul Brouillet
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
- Département de Biochimie et Biologie Moléculaire, CHU de Nîmes, Nîmes, France
| | - Bruno Robert
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Marta Jarlier
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Karen Dumas
- SurgiMAb, 10 Parc Club du Millénaire, 1025 Avenue Henri Becquerel, 34000, Montpellier, France
| | - Pierre Martineau
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - Isabelle Navarro-Teulon
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - David Pépin
- Department of Surgery, Harvard Medical School, Boston, MA, USA
- Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA, USA
| | - Thierry Chardès
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France
- INSERM, U1194, 34298, Montpellier, France
- Université de Montpellier, 34298, Montpellier, France
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France
| | - André Pèlegrin
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Campus Val d'Aurelle, 34298, Montpellier Cedex, France.
- INSERM, U1194, 34298, Montpellier, France.
- Université de Montpellier, 34298, Montpellier, France.
- Institut Régional du Cancer de Montpellier, ICM, 34298, Montpellier, France.
| |
Collapse
|
7
|
Godber OF, Chentouf M, Wall R. Sustainable goat production: modelling optimal performance in extensive systems. Anim Prod Sci 2020. [DOI: 10.1071/an18481] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Context
Strategies for achieving greater ruminant livestock productivity are essential to meet the food demands of growing populations, but sustainable changes are difficult to identify given the inherent complexity of such systems. Systems models can address this issue by allowing the impact of potential changes to be explored.
Aims
To develop a holistic systems model for goat production in an extensive Mediterranean environment which could allow changes in key management factors influencing the system to be investigated.
Methods
Initially, a conceptual comprehensive stock-and-flow model of a representative Mediterranean goat production system was constructed. This was used to identify informative indicators that would represent the overall technical and economic performance of the system. Sub-models were then assembled to build the full systems model. The model was parameterised with data collected over 3 years for goat holdings in northern Morocco. Scenario analysis techniques are used to explore the strategies that optimise performance under climate and feed price challenges.
Key results
Meat production is particularly important during periods of drought when increased meat yields can counteract the expected reduction in milk yields, to protect human food security, prevent excessive rangeland degradation and preserve natural nutritional resources. Feed price shocks during drought can have significant negative impacts on the system and zero feed input is shown to be a more sustainable strategy than reliance on high price feed during drought. Any alternative feed sources need to have a high forage component to reduce grazing periods significantly and promote rangeland preservation.
Implications
A diverse management strategy with a mixed meat and dairy semi-intensive production is more stable than specialised dairy systems and allows goat production and financial viability of intensification to be maintained under climatic stress; maintaining meat production was necessary to optimise performance.
Conclusions
The model allows improved insight into management strategies which could optimise animal husbandry performance in goat subsistence systems. However, the work also demonstrates the difficulty of constructing a truly holistic model since, to be practical, such constructs must necessarily be bounded; parameter selection and the limits to the boundaries imposed are inevitably critical.
Collapse
|
8
|
Leconet W, Chentouf M, du Manoir S, Chevalier C, Sirvent A, Aït-Arsa I, Busson M, Jarlier M, Radosevic-Robin N, Theillet C, Chalbos D, Pasquet JM, Pèlegrin A, Larbouret C, Robert B. Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. Clin Cancer Res 2016; 23:2806-2816. [DOI: 10.1158/1078-0432.ccr-16-1316] [Citation(s) in RCA: 70] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2016] [Revised: 10/11/2016] [Accepted: 11/10/2016] [Indexed: 11/16/2022]
|
9
|
Rigo M, Chentouf M, Pèlegrin A, Chardès T. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells. Cell Immunol 2011; 270:40-6. [PMID: 21489413 DOI: 10.1016/j.cellimm.2011.03.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2010] [Revised: 02/01/2011] [Accepted: 03/24/2011] [Indexed: 11/18/2022]
Abstract
The antibody 13B8.2, which is directed against the CDR3-like loop on the D1 domain of CD4, induces CD4/ZAP-70 reorganization and ceramide release in membrane rafts. Here, we investigated whether CD4/ZAP-70 compartmentalization could be mediated by an effect of 13B8.2 on the Carma1-Bcl10-MALT1 complex in membrane rafts. We report that treatment of CD3/CD28-activated Jurkat T cells with 13B8.2, but not rituximab, excluded Carma1-Bcl10-MALT1 proteins from GM1(+) membrane rafts and concomitantly decreased NF-κB activation. Fluorescence confocal imaging confirmed that Carma1-Bcl10 and Carma1-MALT1 co-patching, observed in GM1(+) membrane rafts following CD3/CD28 activation, were abrogated after a 24h-treatment with 13B8.2. The CD4/ZAP-70 compartmentalization in membrane rafts induced by 13B8.2 is thus related to Carma1-Bcl10-MALT1 raft exclusion.
Collapse
Affiliation(s)
- Maxime Rigo
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France
| | | | | | | |
Collapse
|
10
|
Chentouf M, El Amiri B, Sulon J, Beckers JF, Kirschvink N, Boulanouar B, Bister JL. Pregnancy-Associated Glycoprotein Secretion in North Moroccan Goats. Reprod Domest Anim 2008; 43:696-700. [DOI: 10.1111/j.1439-0531.2007.00973.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Chentouf M, Rigo M, Pelegrin A, Chardes T. Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics. ACTA ACUST UNITED AC 2008. [DOI: 10.2174/187152208787169161] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
12
|
Chentouf M, Rigo M, Pèlegrin A, Chardès T. 532 POSTER A chimerized anti-CD4 monoclonal antibody for the treatment of T cell lymphomas acts through activation of membrane acid sphingomyelinase leading to increased ceramide release and CD4/ZAP-70 protein redistribution in membrane rafts. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)72466-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
13
|
Chentouf M, Ghannam S, Bès C, Troadec S, Cérutti M, Chardès T. Recombinant anti-CD4 antibody 13B8.2 blocks membrane-proximal events by excluding the Zap70 molecule and downstream targets SLP-76, PLC gamma 1, and Vav-1 from the CD4-segregated Brij 98 detergent-resistant raft domains. J Immunol 2007; 179:409-20. [PMID: 17579062 DOI: 10.4049/jimmunol.179.1.409] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The biological effects of rIgG(1) 13B8.2, directed against the CDR3-like loop on the D1 domain of CD4, are partly due to signals that prevent NF-kappaB nuclear translocation, but the precise mechanisms of action, particularly at the level of membrane proximal signaling, remain obscure. We support the hypothesis that rIgG(1) 13B8.2 acts by interfering with the spatiotemporal distribution of signaling or receptor molecules inside membrane rafts. Upon cross-linking of Jurkat T lymphocytes, rIgG(1) 13B8.2 was found to induce an accumulation/retention of the CD4 molecule inside polyoxyethylene-20 ether Brij 98 detergent-resistant membranes at 37 degrees C, together with recruitment of TCR, CD3zeta, p56 Lck, Lyn, and Syk p70 kinases, linker for activation of T cells, and Csk-binding protein/phosphoprotein associated with glycosphingolipid adaptor proteins, and protein kinase Ctheta, but excluded Zap70 and its downstream targets Src homology 2-domain-containing leukocyte protein of 76 kDa, phospholipase Cgamma1, and p95(vav). Analysis of key upstream events such as Zap70 phosphorylation showed that modulation of Tyr(292) and Tyr(319) phosphorylation occurred concomitantly with 13B8.2-induced Zap70 exclusion from the membrane rafts. 13B8.2-induced differential raft partitioning was epitope, cholesterol, and actin dependent but did not require Ab hyper-cross-linking. Fluorescence confocal imaging confirmed the spatiotemporal segregation of the CD4 complex inside rafts and concomitant Zap70 exclusion, which occurred within 10-30 s following rIgG(1) 13B8.2 ligation, reached a plateau at 1 min, and persisted until the end of the 1-h experiment. The differential spatiotemporal partitioning between the CD4 receptor and the Zap70-signaling kinase inside membrane rafts interrupts the proximal signal cross-talk leading to subsequent NF-kappaB nuclear translocation and explains how baculovirus-expressed CD4-CDR3-like-specific rIgG(1) 13B8.2 acts to induce its biological effects.
Collapse
Affiliation(s)
- Myriam Chentouf
- Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche 5236, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, Faculté de Pharmacie, 15 Avenue Charles Flahault, 34093 Montpellier, France
| | | | | | | | | | | |
Collapse
|
14
|
Troadec S, Chentouf M, Cérutti M, Nguyen B, Olive D, Bès C, Chardès T. In Vitro Antitumoral Activity of Baculovirus-expressed Chimeric Recombinant Anti-CD4 Antibody 13B8.2 on T-cell Lymphomas. J Immunother 2007; 30:190-202. [PMID: 17471166 DOI: 10.1097/01.cji.0000211331.61019.26] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
A baculovirus-expressed chimeric recombinant IgG1 (rIgG1) antibody, with Cgamma1 and Ckappa human constant domains, was derived from the murine monoclonal antibody 13B8.2, which is specific for the CDR3-like loop of the CD4 molecule. The recombinant IgG1 antibody 13B8.2 was previously shown to inhibit HIV-1 replication and to abrogate the one-way mixed-lymphocyte reaction and block proliferation of CD3-stimulated peripheral blood CD4 lymphocytes from healthy donors. Before testing this recombinant anti-CD4 antibody in in vivo preclinical trials, in vitro mechanisms of action of rIgG1 13B8.2 were assessed using various CD4 T-cell lymphomas. The baculovirus-expressed rIgG1 13B8.2 antibody led to 14% to 40% proliferation inhibition of the lymphoblastic leukaemia-derived SUP-T1, the acute T lymphoma-derived CCRF-CEM and Jurkat, and the cutaneous T-Cell lymphoma-derived HUT-78 cell lines, but it did not affect the cell cycle nor induce cell apoptosis. rIgG1 antibody 13B8.2 bound the C1q fraction, leading to 9% to 17% complement-mediated lysis of the HUT-78, H9, Sup-T1, and the CCRF-CEM cell lines. No correlation was observed between cell sensitivity to rIgG1 13B8.2-triggered complement-dependent lysis and CD35-, CD46-, CD55-, and CD59-surface expression on T lymphoma cells. Using fluorescence-activated cell sorter analysis, the antibody was shown to bind to FcgammaRI/CD64-transfected IIA1.6, FcgammaRII/CD32-transfected CDw32L, and FcgammaRIII/CD16-transfected Jurkat CD16 cell lines. In correlation with these findings, rIgG1 13B8.2 induced 11% to 31% antibody-dependent cell-mediated cytotoxicity of the CCRF-CEM, SUP-T1, A2.01 CD4, and Jurkat cell lines. These convincing results on the activity of the recombinant chimeric anti-CD4 antibody 13B8.2 have led us to perform in vivo preclinical study in a murine xenograft model of CD4 lymphomas.
Collapse
Affiliation(s)
- Samuel Troadec
- CNRS UMR 5160, Centre de Pharmacologie et Biotechnologie pour la Santé, Faculté de Pharmacie, Montpellier, France
| | | | | | | | | | | | | |
Collapse
|
15
|
Troadec S, Bès C, Chentouf M, Nguyen B, Briant L, Jacquet C, Chebli K, Pugnière M, Roquet F, Cerutti M, Chardès T. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule. Clin Immunol 2006; 119:38-50. [PMID: 16426893 DOI: 10.1016/j.clim.2005.11.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2005] [Revised: 11/14/2005] [Accepted: 11/22/2005] [Indexed: 12/16/2022]
Abstract
A baculovirus-expressed chimeric recombinant IgG1 (rIgG1) antibody, with Cgamma1 and Ckappa human constant domains, was derived from the murine monoclonal antibody (mAb) 13B8.2, which is specific for the CDR3-like loop of the CD4 molecule and which inhibits HIV-1 replication. Chimeric rIgG1 antibody 13B8.2 blocked, in a dose-dependent manner, antigen presentation through inhibition of subsequent IL-2 secretion by stimulated T cells. The one-way mixed lymphocyte reaction was abrogated by previous addition of baculovirus-produced rIgG1 13B8.2 in the T-cell culture. Anti-proliferative activity of rIgG1 was demonstrated on CD3-activated CD4+ T lymphocytes from healthy donors, such effect being associated with reduced IL-2 secretion of activated T cells. On the other hand, no proliferation inhibition was observed on CD4+ T lymphocytes activated with phorbol ester plus ionomycin, suggesting that rIgG1 13B8.2 preferentially acts on a proximal TCR-induced signaling pathway. Treatment of DBA1/J human CD4-transgenic mice with 100 microg of recombinant antibody for three consecutive days led to in vivo recovery of rIgG1 antibody 13B8.2 both coated on murine T lymphocytes and free in mouse serum, without CD4 depletion or down-modulation. These findings predict that the baculovirus-expressed chimeric rIgG1 anti-CD4 antibody 13B8.2 is a promising candidate for immunotherapy.
Collapse
Affiliation(s)
- Samuel Troadec
- CNRS UMR 5160, Centre de Pharmacologie et Biotechnologie pour la Santé, Faculté de Pharmacie, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 5, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Bès C, Troadec S, Chentouf M, Breton H, Lajoix AD, Heitz F, Gross R, Plückthun A, Chardès T. PIN-bodies: a new class of antibody-like proteins with CD4 specificity derived from the protein inhibitor of neuronal nitric oxide synthase. Biochem Biophys Res Commun 2006; 343:334-44. [PMID: 16540093 DOI: 10.1016/j.bbrc.2006.02.126] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2006] [Accepted: 02/06/2006] [Indexed: 11/24/2022]
Abstract
By inserting the CB1 paratope-derived peptide (PDP) from the anti-CD4 13B8.2 antibody binding pocket into each of the three exposed loops of the protein inhibitor of neuronal nitric oxide synthase (PIN), we have combined the anti-CD4 specificity of the selected PDP with the stability, ease of expression/purification, and the known molecular architecture of the phylogenetically well-conserved PIN scaffold protein. Such "PIN-bodies" were able to bind CD4 with a better affinity and specificity than the soluble PDP; additionally, in competitive ELISA experiments, CD4-specific PIN-bodies were more potent inhibitors of the binding of the parental recombinant antibody 13B8.2 to CD4 than the soluble PDP. The efficiency of CD4-specific CB1-inserted PIN-bodies was confirmed in biological assays where these constructs showed higher potencies to block antigen presentation by inhibition of IL-2 secretion and to inhibit the one-way and two-way mixed lymphocyte reactions, compared with soluble anti-CD4 PDP CB1. Insertion of the PDP into the first exposed loop (position 33/34) of PIN appeared to be the most promising scaffold. Taken together, our findings demonstrate that the PIN molecule is a suitable scaffold to expose new peptide loops and generate small artificial ligand-binding products with defined specificities.
Collapse
Affiliation(s)
- Cédric Bès
- CNRS UMR 5160, Centre de Pharmacologie et Biotechnologie pour la Santé, Faculté de Pharmacie, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 5, France.
| | | | | | | | | | | | | | | | | |
Collapse
|